GlassScriptPhysician profile
Ginger I Connor
NPI 1407061179
$4,542.59
in general payments reported to CMS, 2019-2025
36 companies · $918 in 2025
The $918 reported for 2025 was more than what 83% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $309 · 2021: $329 · 2022: $779 · 2023: $784 · 2024: $800 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.59 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $601.93 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $571.21 | 2021-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $431.54 | 2019-2025 | Wegovy |
| Sumitomo Pharma America, INC. | $337.51 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $330.09 | 2021-2025 | |
| Myovant Sciences INC. | $321.70 | 2021-2022 | |
| Lilly USA, LLC | $317.14 | 2024-2025 | Zepbound, Mounjaro |
| Aspira Women'S Health INC | $224.50 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $174.02 | 2020-2025 | Slynd |
| Covidien LP | $157.72 | 2019-2020 | |
| Sage Therapeutics, LLC | $102.80 | 2019-2023 | |
| Evofem Biosciences, INC. | $96.10 | 2021-2022 | |
| Hologic Sales and Service, LLC | $91.00 | 2019-2021 | |
| Exact Sciences Corporation | $78.93 | 2025 | Cologuard Collection Kit |
| Coloplast Corp | $73.92 | 2023-2025 | Altis |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $73.76 | 2025 | Femlyv, Intrarosa, Femring |
| Lupin INC. | $72.97 | 2019-2020 | |
| Nalpropion Pharmaceuticals LLC | $46.27 | 2019 | |
| Currax Pharmaceuticals LLC | $41.75 | 2021-2022 | |
| Organon LLC | $39.98 | 2022 | |
| Therapeuticsmd, INC. | $37.82 | 2019-2022 | |
| Duchesnay USA Incorporated | $35.02 | 2019 | |
| Allergan, INC. | $29.41 | 2019 | |
| Avion Pharmaceuticals | $25.43 | 2020-2021 | |
| Intra-Sana Laboratories | $24.09 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Medtronic, INC. | $23.78 | 2022 | |
| Baxter Healthcare | $21.82 | 2023 | Tisseel |
| Amag Pharmaceuticals, INC. | $19.88 | 2019 | |
| Becton, Dickinson and Company | $19.77 | 2024 | Bd Onclarity |
| Daiichi Sankyo INC. | $18.96 | 2019 | |
| Coopersurgical, INC. | $18.22 | 2024 | Endosee |
| Convatec INC. | $17.88 | 2023 | |
| Axonics, INC. | $17.50 | 2024 | Axonics |
| Meditrina | $17.00 | 2025 | |
| Dysis Medical, INC. | $15.70 | 2020 | |
| Tersera Therapeutics LLC | $15.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.